-
Mashup Score: 31Post-progression data confirm benefits of novel combos NSCLC - 2 month(s) ago
Analyses of FLAURA2, MARIPOSA, MARIPOSA-2 trials provide further guidance on treatments for advanced lung cancer, questions remain about sequencing
Source: dailyreporter.esmo.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 20Subcutaneous administration become as standard for immunotherapy? - 2 month(s) ago
Studies add further evidence of the advantages of this route for delivering immune checkpoint inhibitors for patients and healthcare sustainability
Source: dailyreporter.esmo.orgCategories: General Medicine News, Onc News and JournalsTweet
#ELCC24: Analyses of FLAURA2, MARIPOSA and MARIPOSA-2 trials provide further guidance on treatment choices for advanced lung cancer, but questions remain about optimal sequencing. #ESMODailyReporter 👉https://t.co/D4Sg1PQiv0 @ZPiotrowskaMD https://t.co/MDYdaznLgs